Abstract
This paper begins to build a theoretical framework that would enable the pharmaceutical industry to use network complexity measures as a way to identify drug targets. The variability of a betweenness measure for a network node is examined through different methods of network perturbation. Our results indicate a robustness of betweenness centrality in the identification of target genes.
Similar content being viewed by others
References
Azzarelli B, Miravalle L, Vidal R (2004) Immunolocalization of the oligodendrocyte transcription factor 1 (Olig1) in brain tumors. J Neuropathol Exp Neurol 63:170–179
Bavelas A (1950) Communication patterns in task-oriented groups. J Acoust Soc Am 22(6):725–730
Berscheminski J, Brun J, Speiseder T, Wimmer P, Ip WH, Terzic M, Dobner T, Schreiner S (2016) Sp100A is a tumor suppressor that activates p53-dependent transcription and counteracts E1A/E1B-55K-mediated transformation. Oncogene 35:3178–3189
Boccaletti S, Latora V, Moreno Y, Chavez M, Hwang D-U (2006) Complex networks: structure and dynamics. Phys Rep 424(4–5):175–308
Bonacich P (1987) Power and centrality: a family of measures. Am J Sociol 92(5):1170–1182
Breitkreutz D, Hlatky L, Rietman E, Tuszynski J (2012) Molecular signaling network complexity is correlated with cancer patient survivability. Proc Nat Acad Sci 109(23):9209–9212
Carro MS, Lim WK, Alvarez MJ, Bollo RJ, Zhao X, Snyder EY, Sulman EP, Anne SL, Doetsch F, Colman H, Lasorella A, Aldape K, Califano A, Iavaone A (2010) The transcriptional network for mesenchymal transformation of brain tumours. Nature 463:318–325
Cooper LAD, Gutman DA, Chisolm C, Appin C, Kong J, Rong Y, Kurc T, Van Meir EG, Saltz JH, Moreno CS, Brat DJ (2012) The tumor microenvironment strongly impacts master transcriptional regulators and gene expression class of glioblastoma. Am J Pathol 180(5):2108–2119
Davis FB, Tang H-Y, Shih A, Keating T, Lansing L, Hercbergs A, Fenstermaker RA, Mousa A, Mousa SA, Davis PJ, Lin H-Y (2006) Acting via a cell surface receptor, thyroid hormone is a growth factor for glioma cells. Cancer Res 66:7270–7275
del Rio G, Koschützki D, Coello G (2009) How to identify essential genes from molecular networks? BMC Syst Biol 3(1):102
Epskamp S, Borsboom D, Fried EI (2017) Estimating psychological networks and their accuracy: a tutorial paper. Behav Res Methods 1–18
Freeman LC (1977) A set of measures of centrality based on betweenness. Sociometry 35–41
Han J-DJ, Bertin N, Hao T, Goldberg DS, Berriz GF, Zhang LV, Dupuy D, Walhout AJ, Cusick ME, Roth FP (2004) Evidence for dynamically organized modularity in the yeast protein–protein interaction network. Nature 430(6995):88
Jakovcevski I, Zecevic N (2005) Olig transcription factors are expressed in oligodendrocyte and neuronal cells in human fetal CNS. J Neurosci 25:10064–10073
Jeong H, Mason SP, Barabási A-L, Oltvai ZN (2001) Lethality and centrality in protein networks. Nature 411(6833):41
Lachmann A, Giorgi FM, Lopez G, Califano A (2016) ARACNe-AP: gene network reverse engineering through adaptive partitioning inference of mutual information. Bioinformatics 32(14):2233–2235
Li M, Wang J, Chen X, Wang H, Pan Y (2011) A local average connectivity-based method for identifying essential proteins from the network level. Comput Biol Chem 35(3):143–150
Madhavan S, Zenklusen J-C, Kotliarov Y, Sahni H, Fine HA, Buetow K (2009) Rembrandt: helping personalized medicine become a reality through integrative translational research. Mol Cancer Res 7(2):157–167
Margolin AA, Nemenman I, Basso K, Wiggins C, Stolovitzky G, Dalla Favera R, Califano A (2006) ARACNE: an algorithm for the reconstruction of gene regulatory networks in a mammalian cellular context. BMC Bioinform 7:S7
Mistry D, Wise RP, Dickerson JA (2017) DiffSLC: a graph centrality method to detect essential proteins of a protein–protein interaction network. PLoS ONE 12(11):e0187091
Mo W, Chen J, Patel A, Zhang L, Chau V, Li Y, Cho W, Lim K, Xu J, Lazar AJ et al (2013) CXCR4/CXCL12 mediate autocrine cell-cycle progression in NF1-associated malignant peripheral nerve sheath tumors. Cell 152(5):1077–1090
Motizuki M, Isogaya K, Miyake K, Ikushima H, Kubota T, Miyazono K, Saitoh M, Miyazawa K (2013) Oligodendrocyte transcription factor 1 (Olig1) is a smad cofactor involved in cell motility induced by transforming growth factor-\(\beta \). J Biol Chem 288:18911–18922
Newman ME (2003) The structure and function of complex networks. SIAM Rev 45(2):167–256
Pan Y, Smithson LJ, Ma Y, Hambardzumyan D, Gutmann DH (2017) Ccl5 establishes an autocrine high-grade glioma growth regulatory circuit critical for mesenchymal glioblastoma survival. Oncotarget 8:32977–32989
Pan Y, Duron C, Bush EC, Ma Y, Sims PA, Gutmann DH, Radunskaya A, Hardin J (2018) Graph complexity analysis identifies an ETV5 tumor-specific network in human and murine low-grade glioma. PLoS ONE 13(5):e0190001
Ramadan E, Alinsaif S, Hassan MR (2016) Network topology measures for identifying disease-gene association in breast cancer. BMC Bioinform 17(7):274
Sabo JK, Heine V, Silbereis JC, Schirmer L, Levison SW, Rowitch DH (2017) Olig1 is required for noggin-induced neonatal myelin repair. Ann Neurol 81:560–571
Sahin A, Velten M, Pietsch T, Knuefermann P, Okuducu A, Hahne J, Wernert N (2005) Inactivation of Ets 1 transcription factor by a specific decoy strategy reduces rat C6 glioma cell proliferation and mmp-9 expression. Int J Mol Med 15:771–776
Schlierf B, Friedrich RP, Roerig P, Felsberg J, Reifenberger G, Wegner M (2007) Expression of SoxE and SoxD genes in human gliomas. Neuropathol Appl Neurobiol 33:621–630
Segarra S, Ribeiro A (2016) Stability and continuity of centrality measures in weighted graphs. IEEE Trans Signal Process 64(3):543–555
Selagea L, Mishra A, Anand M, Ross J, Tucker-Burden C, Kong J, Brat DJ (2016) EGFR and C/EBP-\(\beta \) oncogenic signaling is bidirectional in human glioma and varies with the C/EBP-\(\beta \) isoform. FASEB 30:4098–4108
Solga AC, Pong WW, Kim K-Y, Cimino PJ, Toonen JA, Walker J, Wylie T, Magrini V, Griffith M, Griffith OL et al (2015) RNA sequencing of tumor-associated microglia reveals Ccl5 as a stromal chemokine critical for neurofibromatosis-1 glioma growth. Neoplasia 17(10):776–788
Tang X, Wang J, Zhong J, Pan Y (2014) Predicting essential proteins based on weighted degree centrality. IEEE/ACM Trans Comput Biol Bioinform (TCBB) 11(2):407–418
Vallabhajosyula RR, Chakravarti D, Lutfeali S, Ray A, Raval A (2009) Identifying hubs in protein interaction networks. PLoS ONE 4(4):e5344
Wasylyk C, Schlumberger S, Criqui-Filipe P, Wasylyk B (2002) Sp100 interacts with ETS-1 and stimulates its transcriptional activity. Mol Cellul Biol 22:2687–2702
Xie SL, Fan S, Zhang SY, Chen WX, Li QX, Pan GK, Zhang HQ, Wang WW, Weng B, Zhang Z, Li JS, Lin ZY (2018) SOX8 regulates cancer stem-like properties and cisplatin-induced EMT in tongue squamous cell carcinoma by acting on the Wnt\(\beta \)-catenin pathway. Int J Cancer 142:1252–1265
Yin J, Oh Y, Kim J, Kim S, Choi E, Kim T, Hong J, Chang N, Cho H, Sa J, Kim J, Kwon H, Park S, Lin W, Nakano I, Gwak H, Yoo H, Lee S, Lee J, Kim J, Kim S, Nam D, Park M, Park J (2017) Transglutaminase 2 inhibition reverses mesenchymal transdifferentiation of glioma stem cells by regulating C/EPB\(\beta \) signaling. Cancer Res 77:4973–4984
Zhang X, Xu J, Xiao W (2013) A new method for the discovery of essential proteins. PLoS ONE 8(3):e58763
Zhang S, Zhu C, Zhu L, Liu H, Liu S, Zhao N, Wu J, Huang X, Zhang Y, Jin J, Ji T, Ding X (2014) Oncogenicity of the transcription factor SOX8 in hepatocellular carcinoma. Med Oncol 31
Author information
Authors and Affiliations
Corresponding author
Additional information
This work was partially supported by NIH R01CA195692.
Rights and permissions
About this article
Cite this article
Durón, C., Pan, Y., Gutmann, D.H. et al. Variability of Betweenness Centrality and Its Effect on Identifying Essential Genes. Bull Math Biol 81, 3655–3673 (2019). https://doi.org/10.1007/s11538-018-0526-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11538-018-0526-z